nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—Adenosine triphosphate—ACVR1B—coronary artery disease	0.00316	0.211	CrCbGaD
Regadenoson—Adenosine triphosphate—HSPA1A—coronary artery disease	0.00289	0.193	CrCbGaD
Regadenoson—Adenosine monophosphate—CREB1—coronary artery disease	0.00277	0.185	CrCbGaD
Regadenoson—Adenosine—ADORA1—coronary artery disease	0.00246	0.165	CrCbGaD
Regadenoson—Adenosine triphosphate—ABCA1—coronary artery disease	0.00154	0.103	CrCbGaD
Regadenoson—Adenosine triphosphate—AKT1—coronary artery disease	0.00113	0.0758	CrCbGaD
Regadenoson—Adenosine monophosphate—PDE4B—coronary artery disease	0.000999	0.0667	CrCbGaD
Regadenoson—Urticaria—Telmisartan—coronary artery disease	0.000341	0.0005	CcSEcCtD
Regadenoson—Cough—Timolol—coronary artery disease	0.000341	0.000499	CcSEcCtD
Regadenoson—Vomiting—Clopidogrel—coronary artery disease	0.000341	0.000499	CcSEcCtD
Regadenoson—Diarrhoea—Simvastatin—coronary artery disease	0.000341	0.000499	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Furosemide—coronary artery disease	0.00034	0.000499	CcSEcCtD
Regadenoson—Myalgia—Ramipril—coronary artery disease	0.00034	0.000498	CcSEcCtD
Regadenoson—Chest pain—Ramipril—coronary artery disease	0.00034	0.000498	CcSEcCtD
Regadenoson—Arthralgia—Ramipril—coronary artery disease	0.00034	0.000498	CcSEcCtD
Regadenoson—Tremor—Lisinopril—coronary artery disease	0.00034	0.000497	CcSEcCtD
Regadenoson—Abdominal pain—Telmisartan—coronary artery disease	0.00034	0.000497	CcSEcCtD
Regadenoson—Dyspnoea—Losartan—coronary artery disease	0.000339	0.000497	CcSEcCtD
Regadenoson—Anxiety—Ramipril—coronary artery disease	0.000339	0.000497	CcSEcCtD
Regadenoson—Vomiting—Lovastatin—coronary artery disease	0.000339	0.000496	CcSEcCtD
Regadenoson—Somnolence—Losartan—coronary artery disease	0.000338	0.000495	CcSEcCtD
Regadenoson—Dizziness—Eplerenone—coronary artery disease	0.000338	0.000495	CcSEcCtD
Regadenoson—Rash—Clopidogrel—coronary artery disease	0.000338	0.000495	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000338	0.000495	CcSEcCtD
Regadenoson—Dermatitis—Clopidogrel—coronary artery disease	0.000338	0.000495	CcSEcCtD
Regadenoson—Asthenia—Valsartan—coronary artery disease	0.000338	0.000494	CcSEcCtD
Regadenoson—Hypertension—Timolol—coronary artery disease	0.000337	0.000494	CcSEcCtD
Regadenoson—Pain—Furosemide—coronary artery disease	0.000337	0.000494	CcSEcCtD
Regadenoson—Hypersensitivity—Niacin—coronary artery disease	0.000337	0.000494	CcSEcCtD
Regadenoson—Ill-defined disorder—Lisinopril—coronary artery disease	0.000336	0.000493	CcSEcCtD
Regadenoson—Discomfort—Ramipril—coronary artery disease	0.000336	0.000492	CcSEcCtD
Regadenoson—Asthenia—Olmesartan—coronary artery disease	0.000336	0.000492	CcSEcCtD
Regadenoson—Headache—Clopidogrel—coronary artery disease	0.000336	0.000492	CcSEcCtD
Regadenoson—Rash—Lovastatin—coronary artery disease	0.000336	0.000492	CcSEcCtD
Regadenoson—Dermatitis—Lovastatin—coronary artery disease	0.000336	0.000491	CcSEcCtD
Regadenoson—Feeling abnormal—Perindopril—coronary artery disease	0.000334	0.00049	CcSEcCtD
Regadenoson—Headache—Lovastatin—coronary artery disease	0.000334	0.000489	CcSEcCtD
Regadenoson—Myalgia—Timolol—coronary artery disease	0.000333	0.000487	CcSEcCtD
Regadenoson—Chest pain—Timolol—coronary artery disease	0.000333	0.000487	CcSEcCtD
Regadenoson—Arthralgia—Timolol—coronary artery disease	0.000333	0.000487	CcSEcCtD
Regadenoson—Vomiting—Ezetimibe—coronary artery disease	0.000332	0.000486	CcSEcCtD
Regadenoson—Hypersensitivity—Pravastatin—coronary artery disease	0.000332	0.000486	CcSEcCtD
Regadenoson—Gastrointestinal pain—Perindopril—coronary artery disease	0.000332	0.000486	CcSEcCtD
Regadenoson—Anxiety—Timolol—coronary artery disease	0.000332	0.000486	CcSEcCtD
Regadenoson—Angioedema—Lisinopril—coronary artery disease	0.000331	0.000485	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.00033	0.000484	CcSEcCtD
Regadenoson—Abdominal pain—Captopril—coronary artery disease	0.00033	0.000484	CcSEcCtD
Regadenoson—Dizziness—Simvastatin—coronary artery disease	0.000329	0.000483	CcSEcCtD
Regadenoson—Rash—Ezetimibe—coronary artery disease	0.000329	0.000482	CcSEcCtD
Regadenoson—Dermatitis—Ezetimibe—coronary artery disease	0.000329	0.000482	CcSEcCtD
Regadenoson—Discomfort—Timolol—coronary artery disease	0.000329	0.000481	CcSEcCtD
Regadenoson—Asthenia—Niacin—coronary artery disease	0.000328	0.000481	CcSEcCtD
Regadenoson—Headache—Ezetimibe—coronary artery disease	0.000327	0.000479	CcSEcCtD
Regadenoson—Malaise—Lisinopril—coronary artery disease	0.000327	0.000479	CcSEcCtD
Regadenoson—Anaphylactic shock—Ramipril—coronary artery disease	0.000326	0.000478	CcSEcCtD
Regadenoson—Pain—Losartan—coronary artery disease	0.000325	0.000477	CcSEcCtD
Regadenoson—Syncope—Lisinopril—coronary artery disease	0.000325	0.000476	CcSEcCtD
Regadenoson—Vomiting—Eplerenone—coronary artery disease	0.000325	0.000476	CcSEcCtD
Regadenoson—Feeling abnormal—Furosemide—coronary artery disease	0.000325	0.000476	CcSEcCtD
Regadenoson—Nausea—Fenofibrate—coronary artery disease	0.000324	0.000475	CcSEcCtD
Regadenoson—Asthenia—Pravastatin—coronary artery disease	0.000323	0.000473	CcSEcCtD
Regadenoson—Gastrointestinal pain—Furosemide—coronary artery disease	0.000322	0.000472	CcSEcCtD
Regadenoson—Rash—Eplerenone—coronary artery disease	0.000322	0.000472	CcSEcCtD
Regadenoson—Urticaria—Perindopril—coronary artery disease	0.000322	0.000472	CcSEcCtD
Regadenoson—Hypersensitivity—Trandolapril—coronary artery disease	0.000322	0.000472	CcSEcCtD
Regadenoson—Dermatitis—Eplerenone—coronary artery disease	0.000322	0.000472	CcSEcCtD
Regadenoson—Diarrhoea—Valsartan—coronary artery disease	0.000322	0.000471	CcSEcCtD
Regadenoson—Shock—Ramipril—coronary artery disease	0.000321	0.00047	CcSEcCtD
Regadenoson—Hypersensitivity—Enalapril—coronary artery disease	0.000321	0.00047	CcSEcCtD
Regadenoson—Abdominal pain—Perindopril—coronary artery disease	0.000321	0.00047	CcSEcCtD
Regadenoson—Palpitations—Lisinopril—coronary artery disease	0.00032	0.000469	CcSEcCtD
Regadenoson—Diarrhoea—Olmesartan—coronary artery disease	0.00032	0.000469	CcSEcCtD
Regadenoson—Headache—Eplerenone—coronary artery disease	0.00032	0.000469	CcSEcCtD
Regadenoson—Nervous system disorder—Ramipril—coronary artery disease	0.00032	0.000469	CcSEcCtD
Regadenoson—Anaphylactic shock—Timolol—coronary artery disease	0.000319	0.000467	CcSEcCtD
Regadenoson—Loss of consciousness—Lisinopril—coronary artery disease	0.000319	0.000467	CcSEcCtD
Regadenoson—Nausea—Clopidogrel—coronary artery disease	0.000318	0.000466	CcSEcCtD
Regadenoson—Tachycardia—Ramipril—coronary artery disease	0.000318	0.000466	CcSEcCtD
Regadenoson—Skin disorder—Ramipril—coronary artery disease	0.000317	0.000464	CcSEcCtD
Regadenoson—Vomiting—Simvastatin—coronary artery disease	0.000317	0.000464	CcSEcCtD
Regadenoson—Hypersensitivity—Telmisartan—coronary artery disease	0.000317	0.000464	CcSEcCtD
Regadenoson—Cough—Lisinopril—coronary artery disease	0.000316	0.000463	CcSEcCtD
Regadenoson—Nausea—Lovastatin—coronary artery disease	0.000316	0.000463	CcSEcCtD
Regadenoson—Hyperhidrosis—Ramipril—coronary artery disease	0.000315	0.000462	CcSEcCtD
Regadenoson—Rash—Simvastatin—coronary artery disease	0.000314	0.00046	CcSEcCtD
Regadenoson—Dermatitis—Simvastatin—coronary artery disease	0.000314	0.00046	CcSEcCtD
Regadenoson—Asthenia—Trandolapril—coronary artery disease	0.000314	0.00046	CcSEcCtD
Regadenoson—Shock—Timolol—coronary artery disease	0.000314	0.00046	CcSEcCtD
Regadenoson—Feeling abnormal—Losartan—coronary artery disease	0.000314	0.000459	CcSEcCtD
Regadenoson—Urticaria—Furosemide—coronary artery disease	0.000313	0.000459	CcSEcCtD
Regadenoson—Diarrhoea—Niacin—coronary artery disease	0.000313	0.000458	CcSEcCtD
Regadenoson—Nervous system disorder—Timolol—coronary artery disease	0.000313	0.000458	CcSEcCtD
Regadenoson—Asthenia—Enalapril—coronary artery disease	0.000313	0.000458	CcSEcCtD
Regadenoson—Headache—Simvastatin—coronary artery disease	0.000312	0.000457	CcSEcCtD
Regadenoson—Abdominal pain—Furosemide—coronary artery disease	0.000312	0.000457	CcSEcCtD
Regadenoson—Gastrointestinal pain—Losartan—coronary artery disease	0.000311	0.000456	CcSEcCtD
Regadenoson—Dizziness—Valsartan—coronary artery disease	0.000311	0.000456	CcSEcCtD
Regadenoson—Nausea—Ezetimibe—coronary artery disease	0.00031	0.000454	CcSEcCtD
Regadenoson—Skin disorder—Timolol—coronary artery disease	0.00031	0.000454	CcSEcCtD
Regadenoson—Dizziness—Olmesartan—coronary artery disease	0.00031	0.000453	CcSEcCtD
Regadenoson—Myalgia—Lisinopril—coronary artery disease	0.000309	0.000452	CcSEcCtD
Regadenoson—Chest pain—Lisinopril—coronary artery disease	0.000309	0.000452	CcSEcCtD
Regadenoson—Arthralgia—Lisinopril—coronary artery disease	0.000309	0.000452	CcSEcCtD
Regadenoson—Hyperhidrosis—Timolol—coronary artery disease	0.000308	0.000452	CcSEcCtD
Regadenoson—Asthenia—Telmisartan—coronary artery disease	0.000308	0.000452	CcSEcCtD
Regadenoson—Diarrhoea—Pravastatin—coronary artery disease	0.000308	0.000451	CcSEcCtD
Regadenoson—Anxiety—Lisinopril—coronary artery disease	0.000308	0.000451	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000307	0.000449	CcSEcCtD
Regadenoson—Discomfort—Lisinopril—coronary artery disease	0.000305	0.000447	CcSEcCtD
Regadenoson—Hypotension—Ramipril—coronary artery disease	0.000305	0.000447	CcSEcCtD
Regadenoson—Nausea—Eplerenone—coronary artery disease	0.000304	0.000445	CcSEcCtD
Regadenoson—Dizziness—Niacin—coronary artery disease	0.000302	0.000443	CcSEcCtD
Regadenoson—Urticaria—Losartan—coronary artery disease	0.000302	0.000443	CcSEcCtD
Regadenoson—Abdominal pain—Losartan—coronary artery disease	0.000301	0.000441	CcSEcCtD
Regadenoson—Asthenia—Captopril—coronary artery disease	0.0003	0.000439	CcSEcCtD
Regadenoson—Diarrhoea—Trandolapril—coronary artery disease	0.000299	0.000438	CcSEcCtD
Regadenoson—Vomiting—Valsartan—coronary artery disease	0.000299	0.000438	CcSEcCtD
Regadenoson—Diarrhoea—Enalapril—coronary artery disease	0.000298	0.000437	CcSEcCtD
Regadenoson—Hypotension—Timolol—coronary artery disease	0.000298	0.000437	CcSEcCtD
Regadenoson—Dizziness—Pravastatin—coronary artery disease	0.000298	0.000436	CcSEcCtD
Regadenoson—Vomiting—Olmesartan—coronary artery disease	0.000298	0.000436	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000297	0.000435	CcSEcCtD
Regadenoson—Rash—Valsartan—coronary artery disease	0.000297	0.000434	CcSEcCtD
Regadenoson—Dermatitis—Valsartan—coronary artery disease	0.000296	0.000434	CcSEcCtD
Regadenoson—Nausea—Simvastatin—coronary artery disease	0.000296	0.000433	CcSEcCtD
Regadenoson—Anaphylactic shock—Lisinopril—coronary artery disease	0.000296	0.000433	CcSEcCtD
Regadenoson—Rash—Olmesartan—coronary artery disease	0.000295	0.000432	CcSEcCtD
Regadenoson—Insomnia—Ramipril—coronary artery disease	0.000295	0.000432	CcSEcCtD
Regadenoson—Dermatitis—Olmesartan—coronary artery disease	0.000295	0.000432	CcSEcCtD
Regadenoson—Headache—Valsartan—coronary artery disease	0.000295	0.000432	CcSEcCtD
Regadenoson—Diarrhoea—Telmisartan—coronary artery disease	0.000294	0.000431	CcSEcCtD
Regadenoson—Headache—Olmesartan—coronary artery disease	0.000293	0.00043	CcSEcCtD
Regadenoson—Paraesthesia—Ramipril—coronary artery disease	0.000293	0.000429	CcSEcCtD
Regadenoson—Shock—Lisinopril—coronary artery disease	0.000291	0.000426	CcSEcCtD
Regadenoson—Asthenia—Perindopril—coronary artery disease	0.000291	0.000426	CcSEcCtD
Regadenoson—Dyspnoea—Ramipril—coronary artery disease	0.000291	0.000426	CcSEcCtD
Regadenoson—Vomiting—Niacin—coronary artery disease	0.000291	0.000426	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000291	0.000426	CcSEcCtD
Regadenoson—Hypersensitivity—Furosemide—coronary artery disease	0.000291	0.000426	CcSEcCtD
Regadenoson—Somnolence—Ramipril—coronary artery disease	0.00029	0.000425	CcSEcCtD
Regadenoson—Dizziness—Trandolapril—coronary artery disease	0.000289	0.000424	CcSEcCtD
Regadenoson—Tachycardia—Lisinopril—coronary artery disease	0.000289	0.000423	CcSEcCtD
Regadenoson—Insomnia—Timolol—coronary artery disease	0.000288	0.000423	CcSEcCtD
Regadenoson—Rash—Niacin—coronary artery disease	0.000288	0.000422	CcSEcCtD
Regadenoson—Dermatitis—Niacin—coronary artery disease	0.000288	0.000422	CcSEcCtD
Regadenoson—Dizziness—Enalapril—coronary artery disease	0.000288	0.000422	CcSEcCtD
Regadenoson—Skin disorder—Lisinopril—coronary artery disease	0.000287	0.000421	CcSEcCtD
Regadenoson—Headache—Niacin—coronary artery disease	0.000287	0.00042	CcSEcCtD
Regadenoson—Paraesthesia—Timolol—coronary artery disease	0.000286	0.000419	CcSEcCtD
Regadenoson—Vomiting—Pravastatin—coronary artery disease	0.000286	0.000419	CcSEcCtD
Regadenoson—Hyperhidrosis—Lisinopril—coronary artery disease	0.000286	0.000419	CcSEcCtD
Regadenoson—Diarrhoea—Captopril—coronary artery disease	0.000286	0.000419	CcSEcCtD
Regadenoson—Dyspnoea—Timolol—coronary artery disease	0.000284	0.000416	CcSEcCtD
Regadenoson—Dizziness—Telmisartan—coronary artery disease	0.000284	0.000416	CcSEcCtD
Regadenoson—Rash—Pravastatin—coronary artery disease	0.000284	0.000416	CcSEcCtD
Regadenoson—Dermatitis—Pravastatin—coronary artery disease	0.000284	0.000416	CcSEcCtD
Regadenoson—Somnolence—Timolol—coronary artery disease	0.000284	0.000415	CcSEcCtD
Regadenoson—Asthenia—Furosemide—coronary artery disease	0.000283	0.000414	CcSEcCtD
Regadenoson—Headache—Pravastatin—coronary artery disease	0.000282	0.000413	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000282	0.000413	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—P2RY12—coronary artery disease	0.000281	0.00093	CbGpPWpGaD
Regadenoson—Hypersensitivity—Losartan—coronary artery disease	0.00028	0.000411	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	0.00028	0.000926	CbGpPWpGaD
Regadenoson—Nausea—Valsartan—coronary artery disease	0.000279	0.000409	CcSEcCtD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—JAK2—coronary artery disease	0.000279	0.000923	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CASR—coronary artery disease	0.000278	0.000921	CbGpPWpGaD
Regadenoson—Nausea—Olmesartan—coronary artery disease	0.000278	0.000407	CcSEcCtD
Regadenoson—Vomiting—Trandolapril—coronary artery disease	0.000278	0.000407	CcSEcCtD
Regadenoson—Diarrhoea—Perindopril—coronary artery disease	0.000278	0.000407	CcSEcCtD
Regadenoson—Vomiting—Enalapril—coronary artery disease	0.000277	0.000406	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—IL6ST—coronary artery disease	0.000277	0.000916	CbGpPWpGaD
Regadenoson—Hypotension—Lisinopril—coronary artery disease	0.000276	0.000405	CcSEcCtD
Regadenoson—Dizziness—Captopril—coronary artery disease	0.000276	0.000405	CcSEcCtD
Regadenoson—Rash—Trandolapril—coronary artery disease	0.000276	0.000404	CcSEcCtD
Regadenoson—Dermatitis—Trandolapril—coronary artery disease	0.000276	0.000404	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Timolol—coronary artery disease	0.000275	0.000403	CcSEcCtD
Regadenoson—Rash—Enalapril—coronary artery disease	0.000275	0.000402	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—NFKBIA—coronary artery disease	0.000275	0.000908	CbGpPWpGaD
Regadenoson—Dermatitis—Enalapril—coronary artery disease	0.000274	0.000402	CcSEcCtD
Regadenoson—Headache—Trandolapril—coronary artery disease	0.000274	0.000401	CcSEcCtD
Regadenoson—Vomiting—Telmisartan—coronary artery disease	0.000273	0.0004	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—AVPR1A—coronary artery disease	0.000273	0.000903	CbGpPWpGaD
Regadenoson—Asthenia—Losartan—coronary artery disease	0.000273	0.0004	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—BDKRB1—coronary artery disease	0.000273	0.000903	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—GNA12—coronary artery disease	0.000273	0.000903	CbGpPWpGaD
Regadenoson—Headache—Enalapril—coronary artery disease	0.000273	0.0004	CcSEcCtD
Regadenoson—Pain—Timolol—coronary artery disease	0.000273	0.000399	CcSEcCtD
Regadenoson—Nausea—Niacin—coronary artery disease	0.000272	0.000398	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—DGKZ—coronary artery disease	0.000271	0.000897	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LRP8—coronary artery disease	0.000271	0.000897	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—RLN3—coronary artery disease	0.000271	0.000897	CbGpPWpGaD
Regadenoson—Rash—Telmisartan—coronary artery disease	0.000271	0.000397	CcSEcCtD
Regadenoson—Dermatitis—Telmisartan—coronary artery disease	0.000271	0.000396	CcSEcCtD
Regadenoson—Diarrhoea—Furosemide—coronary artery disease	0.00027	0.000395	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.00027	0.000395	CcSEcCtD
Regadenoson—Headache—Telmisartan—coronary artery disease	0.000269	0.000394	CcSEcCtD
Regadenoson—Feeling abnormal—Ramipril—coronary artery disease	0.000269	0.000394	CcSEcCtD
Regadenoson—Dizziness—Perindopril—coronary artery disease	0.000268	0.000393	CcSEcCtD
Regadenoson—Insomnia—Lisinopril—coronary artery disease	0.000268	0.000392	CcSEcCtD
Regadenoson—Nausea—Pravastatin—coronary artery disease	0.000268	0.000392	CcSEcCtD
Regadenoson—Gastrointestinal pain—Ramipril—coronary artery disease	0.000267	0.000391	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—KIT—coronary artery disease	0.000266	0.00088	CbGpPWpGaD
Regadenoson—Paraesthesia—Lisinopril—coronary artery disease	0.000266	0.000389	CcSEcCtD
Regadenoson—Vomiting—Captopril—coronary artery disease	0.000266	0.000389	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—ADM—coronary artery disease	0.000266	0.000879	CbGpPWpGaD
Regadenoson—Dyspnoea—Lisinopril—coronary artery disease	0.000264	0.000386	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—UTS2—coronary artery disease	0.000264	0.000872	CbGpPWpGaD
Regadenoson—Rash—Captopril—coronary artery disease	0.000263	0.000386	CcSEcCtD
Regadenoson—Dermatitis—Captopril—coronary artery disease	0.000263	0.000385	CcSEcCtD
Regadenoson—Somnolence—Lisinopril—coronary artery disease	0.000263	0.000385	CcSEcCtD
Regadenoson—Feeling abnormal—Timolol—coronary artery disease	0.000263	0.000385	CcSEcCtD
Regadenoson—Headache—Captopril—coronary artery disease	0.000262	0.000383	CcSEcCtD
Regadenoson—Gastrointestinal pain—Timolol—coronary artery disease	0.000261	0.000382	CcSEcCtD
Regadenoson—Dizziness—Furosemide—coronary artery disease	0.000261	0.000382	CcSEcCtD
Regadenoson—Diarrhoea—Losartan—coronary artery disease	0.00026	0.000381	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—AES—coronary artery disease	0.00026	0.00086	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EDN2—coronary artery disease	0.00026	0.00086	CbGpPWpGaD
Regadenoson—Nausea—Trandolapril—coronary artery disease	0.00026	0.000381	CcSEcCtD
Regadenoson—Urticaria—Ramipril—coronary artery disease	0.000259	0.00038	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—PDE4B—coronary artery disease	0.000259	0.000856	CbGpPWpGaD
Regadenoson—Nausea—Enalapril—coronary artery disease	0.000259	0.000379	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	0.000259	0.000855	CbGpPWpGaD
Regadenoson—Vomiting—Perindopril—coronary artery disease	0.000258	0.000378	CcSEcCtD
Regadenoson—Abdominal pain—Ramipril—coronary artery disease	0.000258	0.000378	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—EDN1—coronary artery disease	0.000257	0.000849	CbGpPWpGaD
Regadenoson—Rash—Perindopril—coronary artery disease	0.000256	0.000375	CcSEcCtD
Regadenoson—Dermatitis—Perindopril—coronary artery disease	0.000256	0.000374	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000255	0.000374	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—PLCB3—coronary artery disease	0.000255	0.000845	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—P2RY12—coronary artery disease	0.000255	0.000845	CbGpPWpGaD
Regadenoson—Nausea—Telmisartan—coronary artery disease	0.000255	0.000374	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—GSK3B—coronary artery disease	0.000255	0.000844	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCL5—coronary artery disease	0.000255	0.000843	CbGpPWpGaD
Regadenoson—Headache—Perindopril—coronary artery disease	0.000254	0.000372	CcSEcCtD
Regadenoson—Urticaria—Timolol—coronary artery disease	0.000253	0.000371	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—CREB1—coronary artery disease	0.000253	0.000838	CbGpPWpGaD
Regadenoson—Pain—Lisinopril—coronary artery disease	0.000253	0.000371	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CX3CR1—coronary artery disease	0.000253	0.000836	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CASR—coronary artery disease	0.000253	0.000836	CbGpPWpGaD
Regadenoson—Abdominal pain—Timolol—coronary artery disease	0.000252	0.000369	CcSEcCtD
Regadenoson—Dizziness—Losartan—coronary artery disease	0.000252	0.000369	CcSEcCtD
Regadenoson—Vomiting—Furosemide—coronary artery disease	0.000251	0.000367	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—HRH2—coronary artery disease	0.00025	0.000828	CbGpPWpGaD
Regadenoson—Rash—Furosemide—coronary artery disease	0.000249	0.000364	CcSEcCtD
Regadenoson—Dermatitis—Furosemide—coronary artery disease	0.000248	0.000364	CcSEcCtD
Regadenoson—Nausea—Captopril—coronary artery disease	0.000248	0.000363	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—BDKRB1—coronary artery disease	0.000248	0.00082	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GNA12—coronary artery disease	0.000248	0.00082	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CX3CL1—coronary artery disease	0.000248	0.00082	CbGpPWpGaD
Regadenoson—Headache—Furosemide—coronary artery disease	0.000247	0.000362	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—IL6R—coronary artery disease	0.000247	0.000817	CbGpPWpGaD
Regadenoson—Feeling abnormal—Lisinopril—coronary artery disease	0.000244	0.000357	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—PPP3R1—coronary artery disease	0.000243	0.000805	CbGpPWpGaD
Regadenoson—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000242	0.000354	CcSEcCtD
Regadenoson—Vomiting—Losartan—coronary artery disease	0.000242	0.000354	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—ADM—coronary artery disease	0.000241	0.000798	CbGpPWpGaD
Regadenoson—Nausea—Perindopril—coronary artery disease	0.000241	0.000353	CcSEcCtD
Regadenoson—Hypersensitivity—Ramipril—coronary artery disease	0.00024	0.000352	CcSEcCtD
Regadenoson—Rash—Losartan—coronary artery disease	0.00024	0.000351	CcSEcCtD
Regadenoson—Dermatitis—Losartan—coronary artery disease	0.00024	0.000351	CcSEcCtD
Regadenoson—Headache—Losartan—coronary artery disease	0.000238	0.000349	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR3—coronary artery disease	0.000237	0.000783	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	0.000236	0.000779	CbGpPWpGaD
Regadenoson—Urticaria—Lisinopril—coronary artery disease	0.000235	0.000344	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—PDE4B—coronary artery disease	0.000235	0.000777	CbGpPWpGaD
Regadenoson—Hypersensitivity—Timolol—coronary artery disease	0.000235	0.000344	CcSEcCtD
Regadenoson—Nausea—Furosemide—coronary artery disease	0.000234	0.000343	CcSEcCtD
Regadenoson—Asthenia—Ramipril—coronary artery disease	0.000234	0.000343	CcSEcCtD
Regadenoson—Abdominal pain—Lisinopril—coronary artery disease	0.000234	0.000343	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	0.00023	0.000762	CbGpPWpGaD
Regadenoson—Asthenia—Timolol—coronary artery disease	0.000229	0.000335	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—RHOC—coronary artery disease	0.000227	0.000752	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ACVR1B—coronary artery disease	0.000227	0.000752	CbGpPWpGaD
Regadenoson—Nausea—Losartan—coronary artery disease	0.000226	0.000331	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—HTR2A—coronary artery disease	0.000225	0.000743	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—C3—coronary artery disease	0.000224	0.000742	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—FGF2—coronary artery disease	0.000224	0.000741	CbGpPWpGaD
Regadenoson—Diarrhoea—Ramipril—coronary artery disease	0.000223	0.000327	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL2—coronary artery disease	0.000223	0.000736	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NEDD4—coronary artery disease	0.000221	0.000731	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—F2R—coronary artery disease	0.00022	0.000728	CbGpPWpGaD
Regadenoson—Diarrhoea—Timolol—coronary artery disease	0.000218	0.00032	CcSEcCtD
Regadenoson—Hypersensitivity—Lisinopril—coronary artery disease	0.000218	0.000319	CcSEcCtD
Regadenoson—Dizziness—Ramipril—coronary artery disease	0.000216	0.000316	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—RAMP2—coronary artery disease	0.000215	0.000713	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PF4—coronary artery disease	0.000215	0.000713	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDE3A—coronary artery disease	0.000215	0.000713	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MDK—coronary artery disease	0.000215	0.000713	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCR3—coronary artery disease	0.000215	0.000711	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—JAK2—coronary artery disease	0.000215	0.00071	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—EDNRB—coronary artery disease	0.000213	0.000705	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—AGT—coronary artery disease	0.000213	0.000705	CbGpPWpGaD
Regadenoson—Asthenia—Lisinopril—coronary artery disease	0.000212	0.000311	CcSEcCtD
Regadenoson—Dizziness—Timolol—coronary artery disease	0.000211	0.000309	CcSEcCtD
Regadenoson—Vomiting—Ramipril—coronary artery disease	0.000207	0.000304	CcSEcCtD
Regadenoson—Rash—Ramipril—coronary artery disease	0.000206	0.000301	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—NPY5R—coronary artery disease	0.000206	0.00068	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—F2RL1—coronary artery disease	0.000206	0.00068	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—RALBP1—coronary artery disease	0.000206	0.00068	CbGpPWpGaD
Regadenoson—Dermatitis—Ramipril—coronary artery disease	0.000206	0.000301	CcSEcCtD
Regadenoson—Headache—Ramipril—coronary artery disease	0.000204	0.000299	CcSEcCtD
Regadenoson—Vomiting—Timolol—coronary artery disease	0.000203	0.000297	CcSEcCtD
Regadenoson—Diarrhoea—Lisinopril—coronary artery disease	0.000202	0.000297	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CCL3—coronary artery disease	0.000202	0.000669	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL2—coronary artery disease	0.000202	0.000669	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—EDNRA—coronary artery disease	0.000201	0.000666	CbGpPWpGaD
Regadenoson—Rash—Timolol—coronary artery disease	0.000201	0.000295	CcSEcCtD
Regadenoson—Dermatitis—Timolol—coronary artery disease	0.000201	0.000294	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—ADRB1—coronary artery disease	0.0002	0.000663	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—F2R—coronary artery disease	0.0002	0.000661	CbGpPWpGaD
Regadenoson—Headache—Timolol—coronary artery disease	0.0002	0.000293	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—FZD2—coronary artery disease	0.000197	0.000652	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—UTS2R—coronary artery disease	0.000197	0.000652	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—F2—coronary artery disease	0.000197	0.000651	CbGpPWpGaD
Regadenoson—Dizziness—Lisinopril—coronary artery disease	0.000196	0.000287	CcSEcCtD
Regadenoson—Nausea—Ramipril—coronary artery disease	0.000194	0.000284	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—EDNRB—coronary artery disease	0.000194	0.00064	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SFRP2—coronary artery disease	0.000193	0.000639	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADORA1—coronary artery disease	0.00019	0.000627	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOA4—coronary artery disease	0.00019	0.000627	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADORA3—coronary artery disease	0.00019	0.000627	CbGpPWpGaD
Regadenoson—Nausea—Timolol—coronary artery disease	0.000189	0.000277	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL12—coronary artery disease	0.000189	0.000626	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—BDKRB2—coronary artery disease	0.000189	0.000626	CbGpPWpGaD
Regadenoson—Vomiting—Lisinopril—coronary artery disease	0.000188	0.000276	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—CASP3—coronary artery disease	0.000187	0.00062	CbGpPWpGaD
Regadenoson—Rash—Lisinopril—coronary artery disease	0.000187	0.000273	CcSEcCtD
Regadenoson—Dermatitis—Lisinopril—coronary artery disease	0.000186	0.000273	CcSEcCtD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—coronary artery disease	0.000186	0.000616	CbGpPWpGaD
Regadenoson—Headache—Lisinopril—coronary artery disease	0.000185	0.000271	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—PLCB1—coronary artery disease	0.000185	0.000612	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PPBP—coronary artery disease	0.000183	0.000606	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PGF—coronary artery disease	0.000183	0.000606	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—EDNRA—coronary artery disease	0.000183	0.000605	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	0.000182	0.000603	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ADRB1—coronary artery disease	0.000182	0.000602	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR7—coronary artery disease	0.000181	0.000599	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ITGA2B—coronary artery disease	0.00018	0.000596	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—DVL1—coronary artery disease	0.00018	0.000596	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—POMC—coronary artery disease	0.000179	0.000593	CbGpPWpGaD
Regadenoson—Nausea—Lisinopril—coronary artery disease	0.000176	0.000257	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—CCL2—coronary artery disease	0.000175	0.000581	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—OPRD1—coronary artery disease	0.000175	0.000578	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GHR—coronary artery disease	0.000175	0.000578	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL4—coronary artery disease	0.000175	0.000578	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—KNG1—coronary artery disease	0.000172	0.00057	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL12—coronary artery disease	0.000172	0.000568	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—BDKRB2—coronary artery disease	0.000172	0.000568	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—AGTR1—coronary artery disease	0.000171	0.000566	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PLCB1—coronary artery disease	0.000168	0.000556	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TLE4—coronary artery disease	0.000168	0.000554	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MEF2A—coronary artery disease	0.000168	0.000554	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL10—coronary artery disease	0.000167	0.000553	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR7—coronary artery disease	0.000165	0.000544	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOA2—coronary artery disease	0.000163	0.00054	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—ADRB2—coronary artery disease	0.000162	0.000537	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—coronary artery disease	0.000162	0.000534	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AVPR1A—coronary artery disease	0.000161	0.000534	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PRKCE—coronary artery disease	0.00016	0.00053	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—KNG1—coronary artery disease	0.000156	0.000517	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—UTS2—coronary artery disease	0.000156	0.000515	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—AGTR1—coronary artery disease	0.000155	0.000514	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NR4A1—coronary artery disease	0.000152	0.000504	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL10—coronary artery disease	0.000152	0.000502	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HDAC9—coronary artery disease	0.000151	0.000499	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PLCB3—coronary artery disease	0.000151	0.000499	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—P2RY12—coronary artery disease	0.000151	0.000499	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CX3CR1—coronary artery disease	0.000149	0.000494	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CASR—coronary artery disease	0.000149	0.000494	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ADRB2—coronary artery disease	0.000147	0.000488	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CX3CL1—coronary artery disease	0.000146	0.000484	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—P4HB—coronary artery disease	0.000146	0.000484	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—BDKRB1—coronary artery disease	0.000146	0.000484	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GNA12—coronary artery disease	0.000146	0.000484	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—IL6—coronary artery disease	0.000146	0.000483	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PRKCE—coronary artery disease	0.000146	0.000482	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—EDN1—coronary artery disease	0.000145	0.00048	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCL5—coronary artery disease	0.000144	0.000476	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PPP3R1—coronary artery disease	0.000144	0.000476	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—MAPK1—coronary artery disease	0.000143	0.000474	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—coronary artery disease	0.000143	0.000473	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADM—coronary artery disease	0.000142	0.000471	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CSF2—coronary artery disease	0.000142	0.000469	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDE4B—coronary artery disease	0.000139	0.000459	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CYBB—coronary artery disease	0.000139	0.000459	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CXCL8—coronary artery disease	0.000139	0.000459	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—MMP3—coronary artery disease	0.000139	0.000458	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—coronary artery disease	0.000132	0.000437	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—EDN1—coronary artery disease	0.000132	0.000436	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL5—coronary artery disease	0.000131	0.000432	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PRKCD—coronary artery disease	0.00013	0.000429	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CSF2—coronary artery disease	0.000129	0.000426	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCR3—coronary artery disease	0.000127	0.00042	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR2A—coronary artery disease	0.000127	0.00042	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—C3—coronary artery disease	0.000127	0.000419	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CRK—coronary artery disease	0.000125	0.000415	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—PIK3CA—coronary artery disease	0.000124	0.000411	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ATP2A2—coronary artery disease	0.000124	0.000409	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VWF—coronary artery disease	0.000124	0.000409	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SH2B3—coronary artery disease	0.000124	0.000409	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOC3—coronary artery disease	0.000123	0.000407	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LDLR—coronary artery disease	0.000122	0.000404	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—AGT—coronary artery disease	0.00012	0.000398	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PPP2CA—coronary artery disease	0.00012	0.000397	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL2—coronary artery disease	0.000119	0.000395	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL3—coronary artery disease	0.000119	0.000395	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SDC1—coronary artery disease	0.000118	0.000391	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—F2R—coronary artery disease	0.000118	0.000391	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PRKCD—coronary artery disease	0.000118	0.00039	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FGB—coronary artery disease	0.000116	0.000382	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR2A—coronary artery disease	0.000115	0.000381	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—C3—coronary artery disease	0.000115	0.000381	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EDNRB—coronary artery disease	0.000114	0.000378	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—THBS1—coronary artery disease	0.000113	0.000373	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PSMB5—coronary artery disease	0.000112	0.000369	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PSMA6—coronary artery disease	0.000112	0.000369	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—F2—coronary artery disease	0.000111	0.000368	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—IL6—coronary artery disease	0.00011	0.000364	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—AGT—coronary artery disease	0.000109	0.000362	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EDNRA—coronary artery disease	0.000108	0.000357	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADRB1—coronary artery disease	0.000107	0.000356	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CYBA—coronary artery disease	0.000107	0.000356	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—DUSP6—coronary artery disease	0.000107	0.000354	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PLAT—coronary artery disease	0.000105	0.000348	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL12—coronary artery disease	0.000102	0.000336	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—BDKRB2—coronary artery disease	0.000102	0.000336	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—AKT1—coronary artery disease	0.000101	0.000336	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—POMC—coronary artery disease	0.000101	0.000335	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—F2—coronary artery disease	0.000101	0.000334	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6ST—coronary artery disease	0.000101	0.000333	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—JUNB—coronary artery disease	9.96e-05	0.00033	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PLCB1—coronary artery disease	9.93e-05	0.000328	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR7—coronary artery disease	9.72e-05	0.000322	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ITGAV—coronary artery disease	9.26e-05	0.000306	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—KNG1—coronary artery disease	9.23e-05	0.000306	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—POMC—coronary artery disease	9.2e-05	0.000305	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CREB1—coronary artery disease	9.2e-05	0.000305	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AGTR1—coronary artery disease	9.18e-05	0.000304	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL2—coronary artery disease	9.01e-05	0.000298	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6R—coronary artery disease	8.98e-05	0.000297	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL10—coronary artery disease	8.97e-05	0.000297	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PLG—coronary artery disease	8.95e-05	0.000296	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADRB2—coronary artery disease	8.71e-05	0.000288	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PRKCE—coronary artery disease	8.6e-05	0.000284	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—JAK2—coronary artery disease	8.59e-05	0.000284	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SOCS1—coronary artery disease	8.58e-05	0.000284	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—S100B—coronary artery disease	8.56e-05	0.000283	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SOCS3—coronary artery disease	8.47e-05	0.00028	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—KITLG—coronary artery disease	8.37e-05	0.000277	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TGFBR2—coronary artery disease	8.37e-05	0.000277	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MMP3—coronary artery disease	8.18e-05	0.000271	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—STAT5A—coronary artery disease	8.18e-05	0.000271	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOB—coronary artery disease	7.91e-05	0.000262	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL8—coronary artery disease	7.84e-05	0.000259	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—JAK2—coronary artery disease	7.8e-05	0.000258	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EDN1—coronary artery disease	7.78e-05	0.000257	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL5—coronary artery disease	7.72e-05	0.000255	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CSF2—coronary artery disease	7.61e-05	0.000252	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FGF1—coronary artery disease	7.61e-05	0.000252	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LPL—coronary artery disease	7.55e-05	0.00025	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MEF2C—coronary artery disease	7.48e-05	0.000248	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—RPS6KB1—coronary artery disease	7.48e-05	0.000248	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ITGB3—coronary artery disease	7.29e-05	0.000241	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL8—coronary artery disease	7.12e-05	0.000236	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PPP2CA—coronary artery disease	7.08e-05	0.000234	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PRKCD—coronary artery disease	6.96e-05	0.00023	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR2A—coronary artery disease	6.81e-05	0.000225	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—C3—coronary artery disease	6.8e-05	0.000225	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HIF1A—coronary artery disease	6.48e-05	0.000215	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AGT—coronary artery disease	6.46e-05	0.000214	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LEP—coronary artery disease	6.33e-05	0.000209	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOE—coronary artery disease	6.33e-05	0.000209	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOA1—coronary artery disease	6.26e-05	0.000207	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—KDR—coronary artery disease	6.2e-05	0.000205	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MAPK14—coronary artery disease	6.16e-05	0.000204	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ESR1—coronary artery disease	6.04e-05	0.0002	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FN1—coronary artery disease	5.97e-05	0.000197	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—F2—coronary artery disease	5.97e-05	0.000197	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6ST—coronary artery disease	5.94e-05	0.000197	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NFKBIA—coronary artery disease	5.9e-05	0.000195	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—KIT—coronary artery disease	5.71e-05	0.000189	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GSK3B—coronary artery disease	5.48e-05	0.000181	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—POMC—coronary artery disease	5.44e-05	0.00018	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CREB1—coronary artery disease	5.44e-05	0.00018	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL2—coronary artery disease	5.32e-05	0.000176	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6R—coronary artery disease	5.3e-05	0.000175	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IGF1—coronary artery disease	5.23e-05	0.000173	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—MAPK1—coronary artery disease	5.21e-05	0.000172	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.97e-05	0.000165	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SERPINE1—coronary artery disease	4.97e-05	0.000164	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FGF2—coronary artery disease	4.81e-05	0.000159	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOS3—coronary artery disease	4.74e-05	0.000157	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—JAK2—coronary artery disease	4.61e-05	0.000152	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PIK3CA—coronary artery disease	4.52e-05	0.000149	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL8—coronary artery disease	4.21e-05	0.000139	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—AKT1—coronary artery disease	4.06e-05	0.000134	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CASP3—coronary artery disease	4.03e-05	0.000133	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6—coronary artery disease	4e-05	0.000132	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCND1—coronary artery disease	3.92e-05	0.00013	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MMP9—coronary artery disease	3.8e-05	0.000126	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—AKT1—coronary artery disease	3.69e-05	0.000122	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VEGFA—coronary artery disease	3.42e-05	0.000113	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TGFB1—coronary artery disease	3.14e-05	0.000104	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MAPK1—coronary artery disease	3.07e-05	0.000102	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PIK3CA—coronary artery disease	2.67e-05	8.83e-05	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6—coronary artery disease	2.36e-05	7.82e-05	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AKT1—coronary artery disease	2.18e-05	7.21e-05	CbGpPWpGaD
